Atlas Trials

Evaluation of the Safety and Effectiveness of Switching From Humira® to Imraldi® in Flanders

Clinical trial NCT04045782 · COMPLETED

Trial details

NCT number
NCT04045782
Sponsor
Pieter Dewint, MD PhD
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Inflammatory Bowel Diseases
Start date
2019-08-19
Primary completion
2021-01-29
Enrollment
130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.